Marco Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-42,350
| Closed | -$144K | – | 194 |
|
|
2018
Q3 | $144K | Sell |
42,350
-5,000
| -11% | -$17K | 0.02% | 184 |
|
|
2018
Q2 | $178K | Sell |
47,350
-1,000
| -2% | -$3.76K | 0.03% | 175 |
|
|
2018
Q1 | $198K | Sell |
48,350
-2,000
| -4% | -$8.19K | 0.03% | 171 |
|
|
2017
Q4 | $234K | Buy |
50,350
+5,000
| +11% | +$23.2K | 0.04% | 165 |
|
|
2017
Q3 | $322K | Hold |
45,350
| – | – | 0.05% | 160 |
|
|
2017
Q2 | $328K | Hold |
45,350
| – | – | 0.05% | 157 |
|
|
2017
Q1 | $279K | Hold |
45,350
| – | – | 0.05% | 161 |
|
|
2016
Q4 | $266K | Sell |
45,350
-4,000
| -8% | -$23.5K | 0.05% | 165 |
|
|
2016
Q3 | $262K | Buy |
49,350
+3,000
| +6% | +$15.9K | 0.05% | 160 |
|
|
2016
Q2 | $307K | Hold |
46,350
| – | – | 0.06% | 156 |
|
|
2016
Q1 | $216 | Hold |
46,350
| – | – | 0.03% | 179 |
|
|
2015
Q4 | $234K | Buy |
+46,350
| New | +$234K | 0.04% | 177 |
|
|
2015
Q3 | – | Sell |
-52,100
| Closed | -$520K | – | 197 |
|
|
2015
Q2 | $520K | Hold |
52,100
| – | – | 0.09% | 131 |
|
|
2015
Q1 | $663K | Buy |
52,100
+2,600
| +5% | +$33.1K | 0.12% | 115 |
|
|
2014
Q4 | $700K | Buy |
49,500
+1,000
| +2% | +$14.1K | 0.09% | 118 |
|
|
2014
Q3 | $667K | Sell |
48,500
-750
| -2% | -$10.3K | 0.09% | 115 |
|
|
2014
Q2 | $757K | Sell |
49,250
-3,500
| -7% | -$53.8K | 0.14% | 104 |
|
|
2014
Q1 | $899K | Buy |
52,750
+1,500
| +3% | +$25.6K | 0.19% | 97 |
|
|
2013
Q4 | $664 | Hold |
51,250
| – | – | 0.03% | 108 |
|
|
2013
Q3 | $517K | Hold |
51,250
| – | – | 0.12% | 120 |
|
|
2013
Q2 | $383K | Buy |
+51,250
| New | +$383K | 0.11% | 106 |
|